Prof. Zobair M. Younossi MD

Department of Medicine at Inova Fairfax Hospital, Falls Church, Virginia, USA

Addressing the rising prevalence of non-alcoholic fatty liver disease

Globally, the prevalence of nonalcoholic steatohepatitis (NASH) is rapidly growing. In the U.S. it is now the second leading indicator for liver transplantation and one of the top three causes of liver cancer. In this video, Zobair M. Younossi, Professor and Chairman of the Department of Medicine at Inova Fairfax Hospital in Falls Church, Virginia, discusses the epidemiology of non-alcoholic fatty liver disease (NAFLD), addressing why there is a global need for more awareness and why the current approach to clinical care needs to change.

This video won the Clinical Video Interview of the Year in the 2020 Scientists' Choice Awards. Find out more about the awards here



LIKE 14
Prof. Zobair M. Younossi MD
Liver Disease

Prof. Zobair M. Younossi MD

Biography

Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD, is Professor and Chairman of the Department of Medicine, Inova Fairfax Medical Campus. More
Follow Zobair

Prof. Zobair M. Younossi MD

Department of Medicine at Inova Fairfax Hospital, Falls Church, Virginia, USA

Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, is the Chairman, Department of Medicine, Inova Fairfax Medical Campus. He is also Professor of Medicine, Virginia Commonwealth University, Inova Campus and Affiliate Professor of Biomedical Sciences at George Mason University.